Showing results (161-170 of 186) with videos related to
Sort By:
Pageof 19
Research Square|November 16, 2022
Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individualsJennifer Connors, David Joyner, Nathan Mege, et al.Journal of Medicinal Chemistry|May 17, 2018
Bifunctional Chimera That Coordinately Targets Human Immunodeficiency Virus 1 Envelope gp120 and the Host-Cell CCR5 Coreceptor at the Virus-Cell InterfaceAdel A Rashad, Li-Rui Song, Andrew P Holmes, et al.Meat Science|December 22, 2010
The effects of high pressure processing on pork quality, palatability, and further processed productsC M Souza, D D Boler, D L Clark, et al.Anaerobe|July 23, 2021
Development and clinical validation of an automated cell cytotoxicity neutralization assay for detecting Clostridioides difficile toxins in clinically relevant stools samplesArik Elfassy, Warren V Kalina, Roger French, et al.Virology|August 18, 2009
High dose of plasmid IL-15 inhibits immune responses in an influenza non-human primates immunogenicity modelJiangmei Yin, Anlan Dai, Dominick J Laddy, et al.Vaccine|January 4, 2011
High antibody and cellular responses induced to HIV-1 clade C envelope following DNA vaccines delivered by electroporationJiangmei Yin, Anlan Dai, Jonathan Lecureux, et al.Biorxiv : the Preprint Server for Biology|February 27, 2026
Generation and characterization of a novel MHC-II tetramer for tracking and characterization of toxin B-specific CD4 + T cell responsesJeffrey R Maslanka, Qianxuan She, Kathleen S Krauss, et al.The Journal of Pediatrics|August 7, 2001
Childhood vaccination against varicella: persistence of antibody, duration of protection, and vaccine efficacyS J Vessey, C Y Chan, B J Kuter, et al.Plos One|January 26, 2011
Novel peptides based on HIV-1 gp120 sequence with homology to chemokines inhibit HIV infection in cell cultureOleg Chertov, Ning Zhang, Xin Chen, et al.Vaccine|February 15, 2020
CCR10 expression is required for the adjuvant activity of the mucosal chemokine CCL28 when delivered in the context of an HIV-1 Env DNA vaccineE N Gary, N Kathuria, G Makurumidze, et al.Pageof 19